🟢 Neumora Therapeutics is trading 6% up in pre-market amid a possible broader-market rebound

Neumora Therapeutics is trading at $0.52, up 6.16% in pre-market, possibly reflecting a broader market rebound.

• The stock rose in pre-market after falling 13.96% on November 5; no fresh company announcement was found.
• Nasdaq futures were up 1% after Thursday’s technology-led sell-off, while S&P 500 futures rose 0.3%.
• The next earnings report is expected November 9, not November 6.